1. Home
  2. THTX vs WEA Comparison

THTX vs WEA Comparison

Compare THTX & WEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THTX
  • WEA
  • Stock Information
  • Founded
  • THTX 1993
  • WEA 2002
  • Country
  • THTX Canada
  • WEA United States
  • Employees
  • THTX N/A
  • WEA N/A
  • Industry
  • THTX Biotechnology: Pharmaceutical Preparations
  • WEA Trusts Except Educational Religious and Charitable
  • Sector
  • THTX Health Care
  • WEA Finance
  • Exchange
  • THTX Nasdaq
  • WEA Nasdaq
  • Market Cap
  • THTX 119.1M
  • WEA 127.9M
  • IPO Year
  • THTX N/A
  • WEA N/A
  • Fundamental
  • Price
  • THTX $3.15
  • WEA $10.87
  • Analyst Decision
  • THTX Hold
  • WEA
  • Analyst Count
  • THTX 1
  • WEA 0
  • Target Price
  • THTX N/A
  • WEA N/A
  • AVG Volume (30 Days)
  • THTX 1.0M
  • WEA 46.1K
  • Earning Date
  • THTX 07-09-2025
  • WEA 01-01-0001
  • Dividend Yield
  • THTX N/A
  • WEA 7.87%
  • EPS Growth
  • THTX N/A
  • WEA N/A
  • EPS
  • THTX N/A
  • WEA N/A
  • Revenue
  • THTX $84,378,000.00
  • WEA N/A
  • Revenue This Year
  • THTX N/A
  • WEA N/A
  • Revenue Next Year
  • THTX $15.13
  • WEA N/A
  • P/E Ratio
  • THTX N/A
  • WEA N/A
  • Revenue Growth
  • THTX 2.19
  • WEA N/A
  • 52 Week Low
  • THTX $1.12
  • WEA $9.60
  • 52 Week High
  • THTX $3.20
  • WEA $11.29
  • Technical
  • Relative Strength Index (RSI)
  • THTX 73.34
  • WEA 60.21
  • Support Level
  • THTX $2.28
  • WEA $10.83
  • Resistance Level
  • THTX $3.20
  • WEA $11.04
  • Average True Range (ATR)
  • THTX 0.09
  • WEA 0.11
  • MACD
  • THTX 0.09
  • WEA 0.01
  • Stochastic Oscillator
  • THTX 94.86
  • WEA 60.00

About THTX Theratechnologies Inc.

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.

About WEA Western Asset Bond Fund Share of Beneficial Interest

Western Asset Premier Bond Fund is a diversified closed-end management investment company. Its investment objective is to provide current income and capital appreciation by investing in a diversified portfolio of investment-grade bonds. The Fund invests in sectors, such as financials, energy, telecommunication services, consumer discretionary, healthcare, materials, information technology, and consumer staples.

Share on Social Networks: